Other

2027

West Pharmaceutical Services 2027 remained flat by 0.0% to $1.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.0%, from $1.20M to $1.50M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2026
Last reportedQ1 2026

How to read this metric

An increase indicates higher short-term cash requirements for lease obligations, potentially impacting liquidity, while a decrease suggests reduced short-term lease-related cash outflows.

Detailed definition

This metric captures the total cash outflows required to satisfy finance lease obligations within the upcoming twelve-mo...

Peer comparison

Commonly disclosed in the maturity analysis of lease liabilities for financial institutions.

Metric ID: other_finance_lease_liability_payments_due_next_twelve_months

Historical Data

6 periods
 Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$900.00K$900.00K$1.20M$1.30M$1.50M$1.50M
QoQ Change+0.0%+33.3%+8.3%+15.4%+0.0%
YoY Change+44.4%+66.7%+25.0%
Range$900.00K$1.50M
CAGR+50.5%
Avg YoY Growth+45.4%
Median YoY Growth+44.4%
Current Streak5+ quarters growth

Frequently Asked Questions

What is West Pharmaceutical Services's 2027?
West Pharmaceutical Services (WST) reported 2027 of $1.50M in Q1 2026.
How has West Pharmaceutical Services's 2027 changed year-over-year?
West Pharmaceutical Services's 2027 increased by 25.0% year-over-year, from $1.20M to $1.50M.
What does 2027 mean?
The total amount of finance lease payments due within the next year.